» Articles » PMID: 29574063

Connective Tissue Growth Factor (CTGF) from Basics to Clinics

Overview
Journal Matrix Biol
Publisher Elsevier
Date 2018 Mar 26
PMID 29574063
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Connective tissue growth factor, also known as CCN2, is a cysteine-rich matricellular protein involved in the control of biological processes, such as cell proliferation, differentiation, adhesion and angiogenesis, as well as multiple pathologies, such as tumor development and tissue fibrosis. Here, we describe the molecular and biological characteristics of CTGF, its regulation and various functions in the spectrum of development and regeneration to fibrosis. We further outline the preclinical and clinical studies concerning compounds targeting CTGF in various pathologies with the focus on heart, lung, liver, kidney and solid organ transplantation. Finally, we address the advances and pitfalls of translational fibrosis research and provide suggestions to move towards a better management of fibrosis.

Citing Articles

CCN2 mediates fibroblast-macrophage interaction in knee arthrofibrosis based on single-cell RNA-seq analysis.

Li Z, Jiang J, Cai K, Qiao Y, Zhang X, Wang L Bone Res. 2025; 13(1):26.

PMID: 39994205 PMC: 11850813. DOI: 10.1038/s41413-025-00400-9.


Modulation of TGF-β signaling new approaches toward kidney disease and fibrosis therapy.

Hong Q, Kim H, Cai G, Chen X, He J, Lee K Int J Biol Sci. 2025; 21(4):1649-1665.

PMID: 39990662 PMC: 11844295. DOI: 10.7150/ijbs.101548.


CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting.

Ghosh P, Dey A, Nandi S, Majumder R, Das S, Mandal M Cancer Metastasis Rev. 2025; 44(1):32.

PMID: 39945880 DOI: 10.1007/s10555-025-10248-4.


Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.

Joumaa J, Raffoul A, Sarkis C, Chatrieh E, Zaidan S, Attieh P J Clin Med. 2025; 14(3).

PMID: 39941397 PMC: 11818458. DOI: 10.3390/jcm14030727.


Modified bFGF targeting connective tissue growth factor in the injured microenvironment improved cardiac repair after chronic myocardial ischemia.

Sun S, Zhu F, Xu Q, Hou X, Nie W, Su K Regen Ther. 2025; 28:438-450.

PMID: 39925966 PMC: 11803136. DOI: 10.1016/j.reth.2025.01.006.